Evidence map›Paper›PMID 28922385›Full record

ArticlePLoS neglected tropical diseases2017

Metabolomics analyses identify platelet activating factors and heme breakdown products as Lassa fever biomarkers.

Trevor V Gale, Timothy M Horton, Donald S Grant, Robert F Garry

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Ebola virus-like particles reprogram cellular metabolism.Journal of molecular medicine (Berlin, Germany) · 2023
    Article
  4. Lassa Fever Natural History and Clinical Management.Current topics in microbiology and immunology · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Host Metabolic Response in Early Lyme Disease.Journal of proteome research · 2020
    Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Trevor V GaleDepartment of Microbiology and Immunology, Tulane University, New Orleans, Louisiana, United States of America.
Timothy M HortonDepartment of Microbiology and Immunology, Tulane University, New Orleans, Louisiana, United States of America.
Donald S GrantViral Hemorrhagic Fever Program, Kenema Government Hospital, Kenema, Sierra Leone.
Robert F GarryDepartment of Microbiology and Immunology, Tulane University, New Orleans, Louisiana, United States of America.ORCID http://orcid.org/0000-0002-5683-3250
Tulane University · USUniversity of Sierra Leone · SL

Funding

Mechanistic Virology CoreU19AI109762 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI LAI, JONATHAN R. · 2014 to 2018
$29.6M
Antibody immunotherapeutics for biodefense against Lassa virusR01AI104621 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI GARRY, ROBERT F · 2013 to 2017
$5.8M
Project 2. Expansion of Clinical Research Capacity at Kenema Government HospitalU19AI115589 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI SCHIEFFELIN, JOHN SCRIBNER · 2015 to 2019
$3.6M
Late-stage development toward commercialization of multilineage point-of-care Lassa fever diagnosticsR44AI115754 · NIAID · ZALGEN LABS, LLC · PI BRANCO, LUIS MANUEL · 2015 to 2016
$1.9M
NIAID NIH HHS HHSN272201000022CNIAID NIH HHS HHSN272201400048CNIAID NIH HHS R01 AI104621NIAID NIH HHS R44 AI115754NIAID NIH HHS U19 AI109762NIAID NIH HHS U19 AI115589
6 · The paper itself

Abstract

Lassa fever afflicts tens of thousands of people in West Africa annually. The rapid progression of patients from febrile illness to fulminant syndrome and death provides incentive for development of clinical prognostic markers that can guide case management. The small molecule profile of serum from febrile patients triaged to the Viral Hemorrhagic Fever Ward at Kenema Government Hospital in Sierra Leone was assessed using untargeted Ultra High Performance Liquid Chromatography Mass Spectrometry. Physiological dysregulation resulting from Lassa virus (LASV) infection occurs at the small molecule level. Effects of LASV infection on pathways mediating blood coagulation, and lipid, amino acid, nucleic acid metabolism are manifest in changes in the levels of numerous metabolites in the circulation. Several compounds, including platelet activating factor (PAF), PAF-like molecules and products of heme breakdown emerged as candidates that may prove useful in diagnostic assays to inform better care of Lassa fever patients.

Indexed as

AdolescentAdultAfrica, WesternAntibodies, ViralAntigens, ViralBiomarkersFemaleHemeHumansImmunoglobulin MLassa FeverLassa virusMaleMass SpectrometryMetabolomicsPlatelet Activating FactorAntibodies, ViralAntigens, ViralBiomarkersHemeImmunoglobulin MPlatelet Activating FactorRNA, Viral

Identifiers

PMID28922385
PMCPMC5619842
OpenAlexW2754757414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.